
Elanco Animal Health Hits New 52-Week High at $22.95
2025-11-04 18:02:52Elanco Animal Health, Inc. has achieved a new 52-week high of USD 22.95, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. Over the past year, the company has seen a notable increase, outperforming the S&P 500, while maintaining a favorable P/E ratio and manageable debt levels.
Read full news article
Elanco Animal Health Hits New 52-Week High of $22.86
2025-10-31 16:27:37Elanco Animal Health, Inc. achieved a new 52-week high of USD 22.86 on October 30, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has gained 23.74% over the past year, with a competitive P/E ratio of 14.00 and a manageable debt-to-equity ratio of 0.54.
Read full news article
Elanco Animal Health Hits New 52-Week High of $22.73
2025-10-30 18:50:39Elanco Animal Health, Inc. achieved a new 52-week high of USD 22.73 on October 29, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 23.85% increase over the past year, showcasing significant recovery and growth within its market.
Read full news article





